These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 36780064

  • 1. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
    Na Nakorn K, Piyaphanee N, Sukharomana M, Pinpatanapong R, Charuvanij S.
    Clin Rheumatol; 2023 Jun; 42(6):1655-1664. PubMed ID: 36780064
    [Abstract] [Full Text] [Related]

  • 2. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
    Piga M, Floris A, Cappellazzo G, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Res Ther; 2017 Nov 10; 19(1):247. PubMed ID: 29126432
    [Abstract] [Full Text] [Related]

  • 3. Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort.
    Hao Y, Oon S, Ji L, Gao D, Fan Y, Geng Y, Zhang X, Li G, Morand EF, Nikpour M, Zhang Z.
    Clin Rheumatol; 2022 Feb 10; 41(2):357-366. PubMed ID: 34595670
    [Abstract] [Full Text] [Related]

  • 4. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 10; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 5. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
    Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA.
    Lupus Sci Med; 2022 Feb 10; 9(1):. PubMed ID: 35193948
    [Abstract] [Full Text] [Related]

  • 6. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Kikuchi J, Hanaoka H, Saito S, Oshige T, Hiramoto K, Kaneko Y, Takeuchi T.
    Rheumatology (Oxford); 2022 Aug 30; 61(9):3777-3791. PubMed ID: 35015824
    [Abstract] [Full Text] [Related]

  • 7. Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage.
    Floris A, Piga M, Perra D, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Care Res (Hoboken); 2020 Dec 30; 72(12):1794-1799. PubMed ID: 31600023
    [Abstract] [Full Text] [Related]

  • 8. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW, Bultink IE, Heslinga M, Voskuyl AE.
    Rheumatology (Oxford); 2017 Jan 30; 56(1):121-128. PubMed ID: 27803306
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
    Golder V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra SV, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake BMDB, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Lau CS, Nikpour M, Hoi A, Morand EF, Asia Pacific Lupus Collaboration.
    J Rheumatol; 2024 Aug 01; 51(8):790-797. PubMed ID: 38490668
    [Abstract] [Full Text] [Related]

  • 10. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto LA, Dagna L, Manfredi AA, Bozzolo EP.
    Int J Rheum Dis; 2019 Sep 01; 22(9):1752-1761. PubMed ID: 31379114
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE.
    Cody EM, Wilson BE, Ogbu EA, Huggins JL, Chen C, Qiu T, Ting TV, Flores F, Huang B, Brunner HI.
    Lupus Sci Med; 2023 May 01; 10(1):. PubMed ID: 37253553
    [Abstract] [Full Text] [Related]

  • 12. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study.
    Connelly K, Kandane-Rathnayake R, Hoi A, Louthrenoo W, Hamijoyo L, Cho J, Lateef A, Fen Luo S, Wu YJ, Li Z, Navarra S, Zamora L, Sockalingam S, Hao Y, Zhang Z, Katsumata Y, Harigai M, Oon S, Chan M, Chen YH, Bae SC, O'Neill S, Goldblatt F, Kikuchi J, Takeuchi T, Ling Ng KP, Tugnet N, Basnayake BMDB, Ohkubo N, Tanaka Y, Sing Lau C, Nikpour M, Golder V, Morand EF, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2022 Dec 01; 4(12):e831-e841. PubMed ID: 38261391
    [Abstract] [Full Text] [Related]

  • 13. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
    Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Ann Rheum Dis; 2016 Sep 01; 75(9):1615-21. PubMed ID: 26458737
    [Abstract] [Full Text] [Related]

  • 14. Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study.
    Fan C, Yang T, Zheng S, Liao X, Xie R, Chen S, Li J.
    Front Immunol; 2024 Sep 01; 15():1423035. PubMed ID: 38947321
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study.
    Golder V, Kandane-Rathnayake R, Huq M, Louthrenoo W, Luo SF, Wu YJ, Lateef A, Sockalingam S, Navarra SV, Zamora L, Hamijoyo L, Katsumata Y, Harigai M, Chan M, O'Neill S, Goldblatt F, Lau CS, Li ZG, Hoi A, Nikpour M, Morand EF, Asia Pacific Lupus Collaboration.
    Lancet Rheumatol; 2019 Oct 01; 1(2):e103-e110. PubMed ID: 38229337
    [Abstract] [Full Text] [Related]

  • 16. Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study.
    Golder V, Kandane-Rathnayake R, Huq M, Nim HT, Louthrenoo W, Luo SF, Wu YJ, Lateef A, Sockalingam S, Navarra SV, Zamora L, Hamijoyo L, Katsumata Y, Harigai M, Chan M, O'Neill S, Goldblatt F, Lau CS, Li ZG, Hoi A, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2019 Oct 01; 1(2):e95-e102. PubMed ID: 38229349
    [Abstract] [Full Text] [Related]

  • 17. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI, Rabie M, Hassan RA.
    Clin Rheumatol; 2021 Nov 01; 40(11):4553-4558. PubMed ID: 34142298
    [Abstract] [Full Text] [Related]

  • 18. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 01; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 19. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study.
    Golder V, Kandane-Rathnayake R, Li N, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra SV, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Goldblatt F, Oon S, O'Neill S, Ng K, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Lau CS, Hoi A, Nikpour M, Morand EF, Asia Pacific Lupus Collaboration.
    Lancet Rheumatol; 2024 Aug 01; 6(8):e528-e536. PubMed ID: 38876129
    [Abstract] [Full Text] [Related]

  • 20. Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.
    Golder V, Kandane-Rathnayake R, Hoi AY, Huq M, Louthrenoo W, An Y, Li ZG, Luo SF, Sockalingam S, Lau CS, Lee AL, Mok MY, Lateef A, Franklyn K, Morton S, Navarra ST, Zamora L, Wu YJ, Hamijoyo L, Chan M, O'Neill S, Goldblatt F, Morand EF, Nikpour M, Asia-Pacific Lupus Collaboration.
    Arthritis Res Ther; 2016 Nov 09; 18(1):260. PubMed ID: 27829463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.